NCT01035619View on ClinicalTrials.gov

Pediatric Pharmacokinetics And Safety Study Of Moxidectin

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

April 30, 2011

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
Onchocerciasis
Interventions
DRUG

moxidectin

Single Dose Moxidectin 4 mg

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
collaborator

World Health Organization

OTHER

lead

Pfizer

INDUSTRY